Stem Cells, Autism & Aging: Hope or Hype? | The Aging Well Podcast
Parents of children with autism are increasingly exploring stem cell therapy as a potential treatment option, though scientific consensus remains elusive. The Stem Cell Institute, based in Panama, utilizes what they term “Golden Cells™” – Human Umbilical Cord Tissue Mesenchymal Stem Cells (HUCT MSCs) – in an effort to address symptoms associated with the neurodevelopmental disorder.
Autism spectrum disorder is characterized by challenges in social interaction and communication, often accompanied by sensory sensitivities and behavioral issues. While existing strategies aim to mitigate these effects, stem cell therapy is presented by some clinics as a regenerative approach. The Stem Cell Institute asserts its cells “modulate the immune system, reduce inflammation, and proliferate more efficiently than other types of stem cells,” a claim stemming from two decades of research led by Neil Riordan, PA, PhD.
The therapy involves intravenous infusions of MSCs. Proponents suggest that children with autism may experience diminished oxygenation in the brain and chronic gut inflammation, conditions stem cell therapy is proposed to address. A 2017 study cited by StemCellMedicalCenter.com indicated that 70% of children with autism showed improvement after stem cell treatment, with benefits sustained at six and twelve-month follow-ups. Still, the study’s methodology and peer review status are not detailed in the available information.
Despite growing interest, the scientific community urges caution. A 2023 article published in Front Psychiatry emphasizes the need for “tempering expectations” regarding stem cell therapies for autism. The authors, including Antonio Narzisi of the IRCCS Stella Maris Foundation in Italy and Alycia Halladay of the Autism Science Foundation, point out that even if an effective therapy were developed, it may not be universally applicable due to the heterogeneity of autism. The article likewise highlights the importance of the critical developmental period in relation to treatment efficacy.
Research suggests autism may arise from a combination of genetic predisposition and brain damage occurring around the time of birth. Comorbid conditions frequently associated with autism, such as gastrointestinal issues, metabolic disorders, sleep disturbances, and psychological disorders, can further complicate treatment. BeikeCellTherapy.com reports visible improvements in functional brain imaging, noting better nutrient uptake following stem cell treatment, but details of this research are limited.
The timeframe for observing effects from stem cell therapy varies. While some parents report near-immediate or noticeable changes within two weeks, the Stem Cell Institute generally anticipates initial effects within 3-6 months, with continued improvement over 1-2 years. Current treatments for autism primarily focus on early diagnosis and management to improve quality of life, but advancements in addressing the core features of the disorder remain limited.
The Stem Cell Institute continues to offer stem cell therapy for autism, while researchers continue to investigate the potential benefits and limitations of this approach. No further clinical trials or research updates from the Stem Cell Institute were publicly available as of March 22, 2026.